Companies included in GNOM
This is GNOM's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–51 of 51.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| MRNA | MODERNA, INC. | 76,841 | NS | 7.859408% |
| PRAX | Praxis Precision Medicines Inc | 9,697 | NS | 6.234766% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 47,107 | NS | 5.690605% |
| ILMN | ILLUMINA, INC. | 19,973 | NS | 5.12757% |
| GH | GUARDANT HEALTH, INC. | 26,261 | NS | 4.708169% |
| VRTX | VERTEX PHARMACEUTICALS INCORPORATED | 4,551 | NS | 4.317077% |
| BMRN | BIOMARIN PHARMACEUTICAL INC. | 36,598 | NS | 4.31349% |
| NTRA | NATERA, INC. | 9,843 | NS | 3.909755% |
| BNTX | BioNTech SE | 18,367 | NS | 3.865567% |
| Avidity Biosciences Inc | Avidity Biosciences Inc | 27,249 | NS | 3.745918% |
| QGEN | Qiagen N.V. | 38,211 | NS | 3.63323% |
| CRSP | CRISPR Therapeutics AG | 30,338 | NS | 3.483578% |
| TECH | BIO-TECHNE CORPORATION | 30,603 | NS | 3.447396% |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY | 22,278 | NS | 2.652938% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 3,941 | NS | 2.505079% |
| BNYREPOS | BNYREPOS | 1,252,576 | PA | 2.391549% |
| VCYT | Veracyte Inc | 34,212 | NS | 2.3901% |
| ELI LILLY AND COMPANY | ELI LILLY AND COMPANY | 1,165 | NS | 2.339983% |
| TWST | Twist Bioscience Corp | 25,637 | NS | 2.296679% |
| GILD | GILEAD SCIENCES, INC. | 8,009 | NS | 2.277687% |
| AZN | ASTRAZENECA PLC | 5,706 | NS | 2.276448% |
| BEAM | Beam Therapeutics Inc | 40,627 | NS | 2.207623% |
| TXG | 10X Genomics Inc | 49,124 | NS | 2.161921% |
| LEGN | Legend Biotech Corp | 59,071 | NS | 2.142906% |
| RARE | Ultragenyx Pharmaceutical Inc | 39,779 | NS | 1.776476% |
| WGS | GeneDx Holdings Corp | 11,270 | NS | 1.715189% |
| WVE | WAVE Life Sciences Ltd | 56,445 | NS | 1.501246% |
| Genscript Biotech Corp | Genscript Biotech Corp | 498,918 | NS | 1.454061% |
| SRPT | SAREPTA THERAPEUTICS, INC. | 40,976 | NS | 1.31123% |
| NTLA | INTELLIA THERAPEUTICS, INC. | 45,069 | NS | 1.185775% |
| CDNA | CAREDX, INC. | 22,308 | NS | 0.79904% |
| QURE | Uniqure NV | 24,242 | NS | 0.72344% |
| VIR | Vir Biotechnology Inc | 40,138 | NS | 0.696618% |
| PSNL | Personalis Inc | 23,562 | NS | 0.407582% |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 119,496 | NS | 0.383299% |
| A | AGILENT TECHNOLOGIES, INC. | 1,653 | NS | 0.383085% |
| ROCKET PHARMACEUTICALS, INC. | ROCKET PHARMACEUTICALS, INC. | 37,567 | NS | 0.359351% |
| PRME | Prime Medicine Inc | 40,671 | NS | 0.358758% |
| RGNX | Regenxbio Inc | 20,483 | NS | 0.353539% |
| MYGN | MYRIAD GENETICS, INC. | 39,242 | NS | 0.345404% |
| MLAB | MESA LABORATORIES, INC. | 1,851 | NS | 0.34129% |
| MRVI | Maravai LifeSciences Holdings Inc | 46,674 | NS | 0.317249% |
| STOK | Stoke Therapeutics Inc | 4,522 | NS | 0.314359% |
| LAB | STANDARD BIOTOOLS INC. | 119,323 | NS | 0.257441% |
| FLGT | FULGENT GENETICS, INC. | 8,763 | NS | 0.25649% |
| ARCT | Arcturus Therapeutics Holdings Inc | 15,040 | NS | 0.236332% |
| CRBU | Caribou Biosciences Inc | 59,913 | NS | 0.217345% |
| SANA | Sana Biotechnology Inc | 26,441 | NS | 0.212537% |
| SGMOQ | SANGAMO THERAPEUTICS, INC. | 244,820 | NS | 0.202073% |
| EDIT | EDITAS MEDICINE, INC. | 46,709 | NS | 0.1962% |
| RNA | Atrium Therapeutics Inc | 2,724.9 | NS | 0.076739% |
SEC N-PORT snapshot as of .